Abstract
We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 442-444 |
| Number of pages | 3 |
| Journal | Fertility and sterility |
| Volume | 87 |
| Issue number | 2 |
| DOIs | |
| State | Published - Feb 1 2007 |
| Externally published | Yes |
Fingerprint
ASJC Scopus subject areas
- Reproductive Medicine
- Obstetrics and Gynecology
Cite this
Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome. / McGovern, Peter G.; Legro, Richard S.; Myers, Evan R.; Barnhart, Huiman X.; Carson, Sandra A.; Diamond, Michael P.; Carr, Bruce R.; Schlaff, William D.; Coutifaris, Christos; Steinkampf, Michael P.; Nestler, John E.; Gosman, Gabey; Leppert, Phyllis C.; Giudice, Linda C.
In: Fertility and sterility, Vol. 87, No. 2, 01.02.2007, p. 442-444.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Utility of screening for other causes of infertility in women with "known" polycystic ovary syndrome
AU - McGovern, Peter G.
AU - Legro, Richard S.
AU - Myers, Evan R.
AU - Barnhart, Huiman X.
AU - Carson, Sandra A.
AU - Diamond, Michael P.
AU - Carr, Bruce R.
AU - Schlaff, William D.
AU - Coutifaris, Christos
AU - Steinkampf, Michael P.
AU - Nestler, John E.
AU - Gosman, Gabey
AU - Leppert, Phyllis C.
AU - Giudice, Linda C.
PY - 2007/2/1
Y1 - 2007/2/1
N2 - We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.
AB - We investigated the prevalence of abnormal screening results (questionnaire and testing for other causes of oligo-ovulation, male or tubal factor infertility) in a group of 1,313 oligo-ovulatory women (included and excluded subjects) whose condition was screened for inclusion in the Pregnancy in Polycystic Ovary Syndrome trial, a multicenter clinical trial that was conducted at 13 sites in the United States. Other than failure to demonstrate laboratory evidence of hyperandrogenemia, the most common reasons for subject exclusion were persistent oligospermia and tubal factor infertility.
UR - http://www.scopus.com/inward/record.url?scp=33846588485&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33846588485&partnerID=8YFLogxK
U2 - 10.1016/j.fertnstert.2006.06.050
DO - 10.1016/j.fertnstert.2006.06.050
M3 - Article
C2 - 17141768
AN - SCOPUS:33846588485
VL - 87
SP - 442
EP - 444
JO - Fertility and Sterility
JF - Fertility and Sterility
SN - 0015-0282
IS - 2
ER -